KAREN SIMBARI: Open Payments
NPI 1467837484 · CAMILLUS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,104 in 191 payments from 19 companies in 2025. Trend: 2023 $2,515 · 2024 $2,130 · 2025 $3,104
Food & beverage: $3,093Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $661 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 47 | $480 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $264 |
| Ardelyx, Inc. | 8 | $195 |
| Lilly USA, LLC | 15 | $184 |
| QOL Medical, LLC | 9 | $171 |
| Janssen Biotech, Inc. | 10 | $161 |
| Phathom Pharmaceuticals, Inc. | 13 | $155 |
| Gilead Sciences, Inc. | 8 | $147 |
| Regeneron Healthcare Solutions, Inc. | 4 | $123 |
Products named: XIFAXAN, RINVOQ, IBSRELA, ENTYVIO, OMVOH, DUPIXENT, Sucraid, TREMFYA.
Industry payments across NY — which companies pay providers there.
